Aligos Therapeutics
Pre-clinicalWe discover targeted antiviral therapies for chronic hepatitis B (CHB), COVID-19, and optimized therapeutics for Nonalcoholic Steatohepatitis (NASH).
Founded
2018
Focus
RNA & Gene TherapySmall Molecules
About
We discover targeted antiviral therapies for chronic hepatitis B (CHB), COVID-19, and optimized therapeutics for Nonalcoholic Steatohepatitis (NASH).
Funding History
3Total raised: $275M
PIPE$80MUndisclosedJun 15, 2021
IPO$150MUndisclosedOct 30, 2020
Series A$45MVivo CapitalJan 15, 2018
Company Info
TypePrivate
Founded2018
LocationSouth San Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile